GB202212801D0 - Novel peptides - Google Patents

Novel peptides

Info

Publication number
GB202212801D0
GB202212801D0 GBGB2212801.1A GB202212801A GB202212801D0 GB 202212801 D0 GB202212801 D0 GB 202212801D0 GB 202212801 A GB202212801 A GB 202212801A GB 202212801 D0 GB202212801 D0 GB 202212801D0
Authority
GB
United Kingdom
Prior art keywords
novel peptides
peptides
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2212801.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alligator Bioscience AB
Original Assignee
Alligator Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alligator Bioscience AB filed Critical Alligator Bioscience AB
Priority to GBGB2212801.1A priority Critical patent/GB202212801D0/en
Publication of GB202212801D0 publication Critical patent/GB202212801D0/en
Priority to US17/980,751 priority patent/US11873348B2/en
Priority to CA3237463A priority patent/CA3237463A1/en
Priority to KR1020247018489A priority patent/KR20240099410A/en
Priority to PCT/EP2022/080860 priority patent/WO2023079101A2/en
Priority to PCT/EP2022/080861 priority patent/WO2023079102A2/en
Priority to AU2022381977A priority patent/AU2022381977A1/en
Priority to US18/507,736 priority patent/US20240117074A1/en
Priority to IL312556A priority patent/IL312556A/en
Ceased legal-status Critical Current

Links

GBGB2212801.1A 2021-11-05 2022-09-02 Novel peptides Ceased GB202212801D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2212801.1A GB202212801D0 (en) 2022-09-02 2022-09-02 Novel peptides
US17/980,751 US11873348B2 (en) 2021-11-05 2022-11-04 Peptides
CA3237463A CA3237463A1 (en) 2021-11-05 2022-11-04 Novel peptides
KR1020247018489A KR20240099410A (en) 2021-11-05 2022-11-04 novel polypeptides
PCT/EP2022/080860 WO2023079101A2 (en) 2021-11-05 2022-11-04 Novel polypeptides
PCT/EP2022/080861 WO2023079102A2 (en) 2021-11-05 2022-11-04 Novel peptides
AU2022381977A AU2022381977A1 (en) 2021-11-05 2022-11-04 Novel peptides
US18/507,736 US20240117074A1 (en) 2021-11-05 2023-11-13 Peptides
IL312556A IL312556A (en) 2021-11-05 2024-05-02 Novel peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2212801.1A GB202212801D0 (en) 2022-09-02 2022-09-02 Novel peptides

Publications (1)

Publication Number Publication Date
GB202212801D0 true GB202212801D0 (en) 2022-10-19

Family

ID=83933383

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2212801.1A Ceased GB202212801D0 (en) 2021-11-05 2022-09-02 Novel peptides

Country Status (1)

Country Link
GB (1) GB202212801D0 (en)

Similar Documents

Publication Publication Date Title
IL288412A (en) Peptides
GB202007441D0 (en) Polypeptide
GB202017649D0 (en) Polypeptide
EP4172173A4 (en) Neutrophil-binding peptides
GB202212801D0 (en) Novel peptides
GB202204539D0 (en) Novel peptides
GB202019879D0 (en) Polypeptide
GB202306822D0 (en) Peptides
GB202217153D0 (en) Peptides
GB202209520D0 (en) Peptides
GB202201768D0 (en) Peptides
IL312556A (en) Novel peptides
GB202313820D0 (en) Peptide
GB202113858D0 (en) Peptides
GB202110693D0 (en) Peptides
GB202404497D0 (en) Peptides
IL311773A (en) Peptide
GB202117405D0 (en) Peptide
GB202306711D0 (en) Novel proteins
GB202319601D0 (en) Polypeptide
GB202111675D0 (en) Peptide
AU2023218551A1 (en) Novel peptides
GB202318676D0 (en) Novel polypeptides
GB202318674D0 (en) Novel polypeptides
GB202318675D0 (en) Novel polypeptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)